Skip to main content

Table 2 Baseline characteristics of patients

From: Can high-flow nasal cannula reduce the rate of reintubation in adult patients after extubation? A meta-analysis

  HFNC Control
Author (Year) Age,Years Mean (SD) Man n,(%) SAPS II Mean(SD) APACHE II Mean(SD) Age,Years Mean(SD) Man, n,(%) SAPS II, Mean(SD) APACHE II, Mean(SD)
Corley 2015 63(11.4) 58(72.0%) NR 15(3.6) 65(11.1) 56(76.0%) NR 15.0(3.9)
Fernandez 2017 67.3(12.1) 46(59.0%) NR 11(5.5) 69.7(13.0) 55(71.0%) NR 10.0(6.7)
Futier 2016 62(12.0) 61(56.0%) NR NR 61.0(13.0) 64(57.0%) NR NR
Hernández 2016 51(13.1) 164(62.1%) NR 7 51.8(12.2) 153(58.2%) NR 7
Hernández 2016(2) 64.6(15.4) 186(64.1) NR 11 64.4(15.8) 202(64.3) NR 10
Maggiore 2014 64(17.0) 33(62.3%) 44(16) NR 65.0(18.0) 35(67.3%) 43.0(14.0) NR
Parke 2013 65 129(76.3%) NR NR 66.0 129(75.4%) NR NR
Stéphan 2016 63.8 273(65.9%) 29 NR 63.9 278(66.8%) 28.8 NR
  1. APACHE The Acute Physiologic and Chronic Health Evaluation; COT conventional oxygen therapy; HFNC high flow nasal cannula; NIPPV noninvasive positive pressure ventilation; NR not report; SAPS Simplified Acute Physiologic Score; SD standard derivation; SIRS systemic inflammatory response syndrome